J. Scott Wolchko, President and CEO at FATE THERAPEUTICS INC (FATE), sold 110,000 shares at $54.47 ($5.7M) on 2020-11-12, disclosed to the SEC on 2020-11-16.
Open-market sale of $5.7M FATE by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.61 | 15,202 | $785K | 13.7% |
| 2 | $51.61 | 15,202 | $785K | 13.7% |
| 3 | $52.66 | 2,088 | $110K | 1.9% |
| 4 | $52.66 | 2,088 | $110K | 1.9% |
| 5 | $53.98 | 10,846 | $585K | 10.2% |
| 6 | $53.98 | 10,846 |
| $585K |
| 10.2% |
| 7 | $54.47 | 1,864 | $102K | 1.8% |
| 8 | $54.47 | 1,864 | $102K | 1.8% |
| 9 | $51.03 | 9,846 | $502K | 8.8% |
| 10 | $51.03 | 9,846 | $502K | 8.8% |
| 11 | $51.03 | 10,000 | $510K | 8.9% |
| 12 | $51.03 | 10,154 | $518K | 9.1% |
| 13 | $51.03 | 10,154 | $518K | 9.1% |
| Total | $51.95 avg | 110,000 | $5.7M | 100% |
| Filing → |
| FATE | SELL | 2022-07-25 | $2.4M | — | Filing → |
| FATE | SELL | 2022-04-25 | $2.6M | — | Filing → |
| FATE | SELL | 2022-01-24 | $2.0M | — | Filing → |